CLDN5 and subarachnoid hemorrhage: Ying, G. Y. et al. reported that 300 mg/kg of VPA can effectively decrease the expression and activity of MMP-9 as well as reduce claudin-5 and occludin degradation after subarachnoid hemorrhage (SAH) in rats [45].